Literature DB >> 3124490

Outcome and costs of intensive care. A follow-up study on patients requiring prolonged mechanical ventilation.

J Thoner1.   

Abstract

This historically prospective study analysed hospital costs and long-term outcome in 249 consecutive patients who required intensive care including intermittent positive pressure ventilation (IPPV) for 48 h or more. The mean age of the patients was 46.7 years and the mean duration on IPPV was 9.1 days. Mortality in hospital was 43%, increasing to 54.6% five years after admission. The mean cost per patient treated was 22,823 US dollars (USD (1980 value]. The mean cost to yield one survivor was 40,035 USD. The mean cost per survivor was 26,056 USD, whereas that of a non-survivor was 18,500 USD. The cost-benefit ratio, i.e. calculated cost per year of extended life until the age of 75 years, averaged 1420 USD (range 360-7980 USD). With the exception of patients suffering from cancerous diseases, the cost-benefit ratio found in this study was favourable in comparison to other high-cost medical care. This is further emphasized by the fact that for the years saved, the quality of life was mostly good.

Entities:  

Mesh:

Year:  1987        PMID: 3124490     DOI: 10.1111/j.1399-6576.1987.tb02647.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

Review 1.  Long-term survival from intensive care: a review.

Authors:  Teresa A Williams; Geoffrey J Dobb; Judith C Finn; Steve A R Webb
Journal:  Intensive Care Med       Date:  2005-08-24       Impact factor: 17.440

2.  Early organ dysfunction affects long-term survival in acute pancreatitis patients.

Authors:  Christos Skouras; Alastair J Hayes; Linda Williams; O James Garden; Rowan W Parks; Damian J Mole
Journal:  HPB (Oxford)       Date:  2014-04-09       Impact factor: 3.647

3.  Do Intensive Care Unit treatment modalities predict mortality in geriatric patients: An observational study from an Indian Intensive Care Unit.

Authors:  Kanwalpreet Sodhi; Manender Kumar Singla; Anupam Shrivastava; Namita Bansal
Journal:  Indian J Crit Care Med       Date:  2014-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.